Pharmacokinetics of meloxicam in plasma and urine of horses

American Journal of Veterinary Research

Volumn 65, Issue 11, 2004, Pages 1542-1547

  Toutain, Pierre Louis ^a   Reymond, Nadège ^a   Laroute, Valérie ^a   Garcia, Patrice ^b   Popot, Marie Agnès ^b   Bonnaire, Yves ^b   Hirsch, Alexandra ^c   Narbe, Rudiger ^c  

^a CNRS   (France)

^b Laboratoire des Courses Hippiques   (France)

^c BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MELOXICAM; NONSTEROID ANTIINFLAMMATORY AGENT;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG URINE LEVEL; EXPERIMENTAL ANIMAL; FEEDING; FEMALE; MALE; MULTIPLE DRUG DOSE; NONHUMAN; STEADY STATE;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CROSS-OVER STUDIES; HORSES; MASS SPECTROMETRY; THIAZINES; THIAZOLES; TIME FACTORS;

ANIMALIA; EQUIDAE; EQUUS CABALLUS;

EID: 9444257466     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.2004.65.1542     Document Type: Article

References (11)

1. Toutain PL, Cester CC. Pharmacokinetic-pharmacodynamic relationships and dose response to meloxicam in horses with induced arthritis in the right carpal joint. Am J Vet Res 2004;65:1533-1541.
2. Toutain PL. Pharmacokinetics/pharmacodynamics integration in drug development and dosage regimen optimization for veterinary medicine. AAPS PharmSci [serial online]. 2002;4:38. Available at: www.aapspharmsci.org/view.asp?art=ps040438. Accessed on Jun 3, 2004.
3. Maitho TE, Lees P, Taylor JB. Absorption and pharmacokinetics of phenylbutazone in Welsh Mountain ponies. J Vet Pharmacol Ther 1986;9:26-39.
4. Toutain PL, Lassourd V. Pharmacokinetic/pharmacodynamic approach to assess irrelevant plasma or urine drug concentrations in postcompetition samples for drug control in the horse. Equine Vet J 2002;34:242-249.
5. Gibaldi M, Perrier D. Pharmacokinetics. New York: Marcel Dekker Inc, 1982.
6. Lees P, Sedgwick AD, Higgins AJ, et al. Pharmacodynamics and pharmacokinetics of meloxicam in the horse. Br Vet J 1991;147:97-108.
7. Toda A, Ishii N, Kihara T, et al. Effect of adjuvant-induced arthritis on hepatic drug metabolism in rats. Xenobiotica 1994; 24:603-611.
8. Piquette-Miller M, Jamali F. Influence of severity of inflammation on the disposition kinetics of propranolol enantiomers in ketoprofen-treated and untreated adjuvant arthritis. Drug Metab Dispos 1995;23:240-245.
9. Davies NM, Skjodt NM. Clinical pharmacokinetics of meloxicam. A cyclo-oxygenase-2 preferential nonsteroidal antiinflammatory drug. Clin Pharmacokinet 1999;36:115-126.
10. Busch U, Schmid J, Heinzel G, et al. Pharmacokinetics of meloxicam in animals and the relevance to humans. Drug Metab Dispos 1998;26:576-584.
11. Jaussaud P, Guieu D, Bellon C, et al. Pharmacokinetics of tolfenamic acid in the horse. Equine Vet J Suppl 1992;11:69-72.